Insider Transactions in Q1 2025 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2025
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
10,000
-18.35%
|
$50,000
$5.73 P/Share
|
|
Mar 12
2025
|
Neal Franklin Fowler Director |
SELL
Open market or private sale
|
Direct |
35,000
-25.72%
|
$175,000
$5.83 P/Share
|
|
Mar 06
2025
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+26.13%
|
-
|
|
Mar 06
2025
|
Joseph C Papa President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
282,500
+50.0%
|
-
|
|
Mar 06
2025
|
William Hartzel SVP, Bioservices |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+36.24%
|
-
|
|
Mar 06
2025
|
Simon C Lowry SVP, R&D, CMO |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+40.46%
|
-
|
|
Mar 06
2025
|
Richard S Lindahl EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
146,888
+32.93%
|
-
|
|
Mar 06
2025
|
Paul Anthony Williams SVP, Products Business |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+41.99%
|
-
|
|
Mar 06
2025
|
Jessica Perl SVP, General Counsel, Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+47.75%
|
-
|
|
Mar 05
2025
|
William Hartzel SVP, Bioservices |
SELL
Payment of exercise price or tax liability
|
Direct |
292
-0.62%
|
$1,460
$5.8 P/Share
|
|
Mar 01
2025
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
683
-0.45%
|
$4,781
$7.48 P/Share
|
|
Mar 01
2025
|
Paul Anthony Williams SVP, Products Business |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-0.48%
|
$812
$7.48 P/Share
|
|
Mar 01
2025
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Payment of exercise price or tax liability
|
Direct |
313
-0.27%
|
$2,191
$7.48 P/Share
|
|
Feb 28
2025
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,073
-0.7%
|
$7,511
$7.48 P/Share
|
|
Feb 28
2025
|
Paul Anthony Williams SVP, Products Business |
SELL
Payment of exercise price or tax liability
|
Direct |
382
-1.57%
|
$2,674
$7.48 P/Share
|
|
Feb 12
2025
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,916
-9.89%
|
-
|
|
Feb 12
2025
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,991
-10.74%
|
-
|
|
Feb 09
2025
|
Jessica Perl SVP, General Counsel, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
918
-13.49%
|
$9,180
$10.0 P/Share
|